Jenkem Technology Co., Ltd.

Shanghai Stock Exchange 688356.SS

Jenkem Technology Co., Ltd. EBIT for the year ending December 31, 2023: USD 17.83 M

Jenkem Technology Co., Ltd. EBIT is USD 17.83 M for the year ending December 31, 2023, a -40.85% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Jenkem Technology Co., Ltd. EBIT for the year ending December 31, 2022 was USD 30.14 M, a -5.38% change year over year.
Jenkem Technology Co., Ltd. EBIT for the year ending December 31, 2021 was USD 31.85 M, a 107.30% change year over year.
Jenkem Technology Co., Ltd. EBIT for the year ending December 31, 2020 was USD 15.37 M, a 51.40% change year over year.
Jenkem Technology Co., Ltd. EBIT for the year ending December 31, 2019 was USD 10.15 M, a 63.98% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Shanghai Stock Exchange: 688356.SS

Jenkem Technology Co., Ltd.

CEO	Mr. Xuan Zhao
IPO Date	Aug. 26, 2020
Location	China
Headquarters	Building C-1
Employees	298
Sector	Materials
Industries Plastics 3D Printing Biotechnology Chemicals & Advanced Materials Cleaning Supplies Pet Food Petrochemicals Pharmaceuticals

Description

Jenkem Technology Co., Ltd. develops and manufactures polyethylene glycol derivative (PEG) products in China. The company offers branched, linear, double substituted, heterofunctional double substituted, multi-arm, multi-arm hetero functional double substituted, and monodisperse PEG products, as well as amino, sulfhydryl, and N-terminal pegylated PEG products. It also provides PEGylation services for proteins, peptides, oligonucleotides, and small molecules, as well as custom PEG synthesis of PEG derivatives. The company was founded in 2001 and is based in Beijing, China.

Key trends

Past 5 years